Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

The majority of severe visual loss in the United States results from complications associated with retinal neovascularization in patients with ischemic ocular diseases such as diabetic retinopathy, retinal vein occlusion, and retinopathy of prematurity. Intraocular expression of the angiogenic prote...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Aiello, L P, Pierce, E A, Foley, E D, Takagi, H, Chen, H, Riddle, L, Ferrara, N, King, G L, Smith, L E
Médium: Artigo
Jazyk:Inglês
Vydáno: 1995
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC40630/
https://ncbi.nlm.nih.gov/pubmed/7479819
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky